Rimonabant-a simple solution
Rimonabant is the diet pill that made a huge impression in the obesity treatments. Rimonabant is the main ingredient of Acomplia,the best diet drug in the world right now. The researchers at Sanofi Aventis one of the most highly recognized pharmaceuticals developers in the world are “responsible” with the apperence of this amaizing drug,that helps people to lose weight and not suffering major side effects.

What you can expect from Rimonabant?
There is a simple answer to this question: WEIGHT LOSS. It’s fast, easy and simple. But do not think you must not put any effort if you have many pounds to take of. You must do exercises and keep some restrictions in what you eat and how you eat,if your target is really high.
Rimonabant is recommended to be used on people who have a BMI over 30 or a BMI over 27 with associated risk factors. You must never take it while on anti-depressive medication. Rimonabant should be cautiously in people with moderate renal impairment, epilepsy, people using potent inhibitors and rare hereditary disorders and galactose intolerance. In addition those over 75 should take care when using the Rimonabant. Those who should not take Rimonabant include those with uncontrolled psychological disorders, a cardiovascular event in the last six months and patients who are breastfeeding or pregnant.

Scientist declared that when you start taking rimonabant you will start feel it’s benefits. Don’t worry about side effects, they are normal and will pass when the body gets used with the changes of your metabolism.
You must consult your doctor or a weight loss specialist before you buy rimonabant in order to see if rimonabant is a proper drug for you and how much you will need to take rimonabant. Also tell your doctor about all the medicines you use, (prescription and nonprescription) especially if you take: high blood pressure medicine, MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), any other weight loss pills. Do not start or stop any medicine without doctor or pharmacist approval.

Obesity was a rare occurrence, a few years back. It is no more so. At one time people identified obesity as the cause for some underlying physical disorder or mental disability, so they sought to control excess weigh. But later obesity by and large came to be viewed and specified as being the symbol of good health or good personality. Remarks like “how healthy he looks!” “What a personality he has!” are not uncommon. Even in families where no one is obese, we find children who are either obese from childhood or become obese a few years later.
Obesity also affects youngsters who have reached marriageable age. They find difficulty in getting married as most suitors’ dislike to get saddled with an obese partner especially girls. An overweight male is viewed to be a majestic personality who commands respect and even fear in some cases. However in case of females they are ridiculed, rejected in marriage alliances and even despised in some cases. This is one of the many reasons why women are more figures conscious than men, always seeking various devices than men, always seeking various devices are and health programs to reduce their weight.
Some still equate obesity with perfect health. If one losses a few pounds of excess weight people lament often about how good his health was some days ago and how weak he looked after losing weight. Nevertheless today many people are well informed through various health column, articles and news items published in periodicals & papers about why obesity is not desirable and why one should control excess weight. People now realise that obesity causes a variety of disorders, some of which could prove life threatening.
Obesity put strain on heart, respiratory and eliminatory system. It also increases the chances of diabetes, hypertension and heart diseases. Generally it is seen that obese people are also lower in vitality.

Obesity occurs in mostly two types of people. In stressful people who eat very fast and in excess and secondly in household person who eat from boredom. As the people put on weight they tend to become less happy because of their appearance and become more frustrated. Some people think by taking insufficient food can help in reducing weight. But when they start dieting, body starts to slow down in order to conserve energy and boost its chances of survival. This is why weight loss tends to slow down as we continue to diet. So in a way dieting is not the good method for reducing weight.

The most common cause of obesity is overeating and less physical movement. Overeating problem is coupled with poor diet and also wrong timing of eating said Subodh Gupta, Yoga expert from India. In fact to fight growing obesity among children, some of the schools in the UK are planning to introduce yoga for thousands of young students. This is an excellent step in the direction of fighting the obesity problem of UK.

Yoga practice provides an excellent means for maintaining balanced weight and overcoming obesity problem, provided a daily yoga program is followed with regular routine according to Subodh Gupta Yoga expert based in London.
irst of all we need to find out a reason for this growing mountain of fat that is killing us.

We know now that the traditional explanation - that of overeating - is wrong. People eat when they’re hungry, and they stop when they’re full. The problem lies in hormonal imbalance inside our bodies, an imbalance that deprives us of the energy to live life to the full, and instead stores the energy as fat.

What influences human hormonal balance? The three biggest factors are: genetics, diet, and stress.

There are no prizes for guessing which one of those three is the easiest to control.

The number one nutrient that negatively affects human hormonal balance is well known - it’s sugar. The health and beauty of nations is directly related to its consumption. The per capita consumption of sugar has increased fifteenfold over the last 100 years.

Ever wondered why the French remain slim despite eating far more calories than we do, with their rich, fatty cuisine? That’s right, it’s because they drink wine instead of soft drinks!
The best obesity solution that I can think of is Diet weight control isn’t as easy as it sounds. People often assume that when they reach their target weight that they can stop their diet and they will remain slim and healthy but obviously that is not the case. To continue being slim and healthy you must keep the weight of one preferred method is through diet weight control.

There are a few solutions to obesity available but surgery is maybe the most severe. If you plan on loosing weight try it the healthy safe way many websites and slimming clubs offer up diet plans as a way of getting you to stick to your targets and goals
Therefore achieving desired weight loss. When asked what is a perfect weight people say many different things. Some people think a size 12 is a perfect weight while others think being happy in yourself at your weight is perfect. Health officials have decided the perfect weight is to measure your BMI which is your size to weight ratio.
If you are obese then you need to do something about it as being obese contributes to health problems later on in life such as diabetes and coronary heart disease (CHD).

Obesity solutions do not come in the form of quick weight loss diets and these type of diets should be avoided. Quick fix diets such as the Atkins diet which consists of no carbohydrates and high protein foods is extremely dangerous. These types of weight loss diets are terrible for the body, not only that once the weight is of it is very hard to keep off. Although these diets are recommended by stars such as models and singers it is not safe to use them.
Also the best obesity solution i think its the new drug luched by sanofi aventis(Rimnabant-acomplia).
Acomplia Rimonabant , discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors.

How does Acomplia work?

Acomplia works on the so called endocannabinoid system, which is a system in the brain that affects energy balance, glucose and lipid metabolism and body weight. The result is that patients will experience the feeling of being full easier thus wanting to eat less than normally. This has been proven to significantly help obese patients achieve a weight loss if used in conjunction with a calorie reduced diet and exercise.

Rimonabant for Obesity

Rimonabant Acomplia

Rimonabant Acomplia diet pill is the first in a class of a drug called cannabinoid receptor type1 (CB1) Blockers. Rimonabant (acomplia) diet pill helps people to winning the weight loss battle.

Abdominal fat is a Kingpin of heart disease. Acomplia Rimonabant diet pill reduces fat located in the abdominal area. A substantial drop in weight attributed to taking Acomplia Rimonabant diet pill, constituted lower triglycerides, and improved the HDL cholesterol levels, as well as Rimonabant helped desensitize insulin levels in the blood.

Rimonabant acomplia in clinical test also found to be effective in assisting some smokers to quit smoking. There is a direct relation between obesity and increased risk of cardiovascular disease and diabetes and possibly certain cancers, such as breast and colorectal cancer. Increases in body weight lead to changes in blood lipid and cholesterol levels, predisposing to increased risk
of atherosclerosis.

Rimonabant acomplia has been developed from the knowledge that cannabis smokers often experience extreme hunger pangs, which cannabis smokers refer to as ‘the munchies’.

Rimonabant acomplia the most advanced of any anti-obesity drug in testing and so far, preliminary data from large studies have shown that weight loss is more dramatic than with existing drugs.

How safe is Rimonabant diet pill??

Recent two year study involving Rimonabant (Acomplia) diet pill, The Rimonabant Side effects for those who taking Rimonabant Acomplia, were mild. Some of the side effects of Rimonabant (acomplia) included irritability, depression, and nausea. Acomplia is such a new drug which has few side effects with compare to advantages. As with all drugs, come risks. With obesity come risks. Do the risks from obesity outweigh the risks involved with Rimonabant (acomplia) diet pill? These are questions that the dieter should discuss with their doctors.

Purchase Rimonabant diet pill and start weight loss from today. click here to Order Rimonabant

Order Rimonabant Online

Many legitimate Web sites bring customers health products with the benefits of convenience, privacy, and, sometimes, cheaper prices. “But consumers need to be aware that the Internet has also created a marketplace for unapproved medical products, illegal prescribing, and products marketed with fraudulent health claims. So, Being a responsible website, cesaonline.com encourages visitors to go through all the information available about Rimonabant before order rimonabant acomplia online from UK.

Now it is easy to Order Rimonabant a slimming pill online. Now no more exercise, no more weight loss programs and no more machines to reduce your weight and control it. One wonder durg Rimonabant Acomplia can do all for you. Apart from being an effective weight loss and an anti obesity pill, Rimonabant Acomplia has also shown to improve HDL (good cholesterol) and triglyceride levels, showing benefit for diabetes and heart conditions.

Order Acomplia with the most trusted and reliable source www.lincolnschallengeacademy.com. We are the most trusted name in quality drugs and fastest delivery. Our services gracefully cater discerning worldwide customers. Order Acomplia for miraculous results for weight loss and helps to quit smoke easily without weight gain without any serious side effects.

Order Acomplia with us and say good bye to obesity and smoking ! If left untreated then chances are more for diseases that are caused due to high level of bad cholesterol.with full trust with guaranteed treatment of obesity. Our dedicated customer service is always keen to help you and clear our doubts.

Order Acomplia as it is responsible for losing the weight without any physical efforts. It increases the level of good cholesterol and insulin. It affects the hunger center in brain thus blocking the hunger signals to brain.

Order Rimonabant Acomplia now for losing weight today. Order rimonabant to loss weight safely and effectively.

Rimonabant as a diet pill

    Abdominal fat is a Kingpin of heart disease. Rimonabant Acomplia diet pill reduces fat located in the abdominal area. A substantial drop in weight attributed to taking  Rimonabant  Acomplia diet pill, constituted lower triglycerides, and improved the HDL cholesterol levels, as well as Rimonabant helped desensitize insulin levels in the blood.

How does Rimonabant Acomplia diet pill works??

Rimonabant  Acomplia is a wonder drug of the future in regards to weight loss. Rimonabant  Acomplia   works in suppressing the appetite, thus resulting in weight loss. You can buy Rimonabant acomplia diet pill online for the treatment of obesity. Rimonabant is a miracle pill for effective weight loss.  

Functions of Rimonabant Acomplia

Buy Rimonabant a miracle drug which works by blocking the CB-1 receptors in human brain, which administer the food intake. These CB-1 receptors are found in the Endo-Cannobinoid (EC) system. In simple terms it acts as an appetite suppressant. This makes you eat less than your normal appetite and thus resulting in weight loss.

We all know pill popping isn’t the answer when it comes to losing weight and keeping if off. But clinical trials with a new anti-obesity drug look promising. The drug, called rimonabant, was developed after scientists noticed that cannabis smokers often had increased appetites and frequently experienced the ‘munchies’.

They worked on the idea that if substances from cannabis called cannabinoids stimulated appetite, blocking the cannabinoid receptors in the brain might reduce appetite.

Furthermore, blocking these receptors might also help people to give up smoking as these receptors not only appear to be involved in controlling food intake, but also have a role to play in tobacco dependence.

Earlier trials with the drug, which works by blocking cannabinoid receptors in the brain, have already shown promising results. But now a new study published in medical journal The Lancet, confirms the drug can help with weight loss and reduce the risk factors associated with heart disease.

In the study, more than 1,500 obese people were given a calorie-controlled diet, together with either 5mg or 20mg of rimonabant each day or a dummy drug. After one year, two thirds of the participants taking the largest dose had lost at least 5 percent of their weight. Better still, of these, 39 percent lost more than 10 percent. Meanwhile, patients on the 20mg dose lost on average, 4cm from their waist and risk factors for heart disease including raised cholesterol, insulin resistance and the presence of metabolic syndrome improved.

New Diet Pill - Acomplia / Rimonabant

There has been talk for some time about a new experimental weight loss drug called Acomplia or Rimonabant. It is now being said that Acomplia or Rimonabant is getting closer to approval by the FDA.

The new drug has been undergoing testing and trials over the last few years. The tests with Acomplia against a placebo has shown that it is effective and does show sustained weight loss after two years of taking the drug. The overweight adults who took Acomplia had lost significantly more weight than those not taking Acomplia. The test also showed that it had increased the levels of HDL cholesterol which is good for you.

Acomplia or Rimonabant works by reducing the appetite, blocking certain receptors in the brain. Those that take Acomplia can expect to lose 10% of their body weight in a year. All sounds good to me. I know that dieting isn’t the way to go, and Paul McKenna is right in what he says about changing the way we look at food, but to me if I wasn’t hungry then I wouldn’t eat, or if my appetite was surpressed I may eat less. Plus if all I have to do is remember to take a tablet everyday, and I already have to to balance my thyroid level, then am I onto a winner?

Other Notes
Acomplia (Rimonabant) has not been licensed in the UK for smoking cessation. Whilst during clinical studies the drug clearly demonstrated a reduced craving for nicotine in patients, the drug has only at the moment been approved as an obesity treatment. As this is a prescription medication we strongly advise that you seek to have a face to face consultation with your doctor in the first instance. Our service should not be interpreted as being a replacement to the treatment advice your doctor can provide.

Beware of Generic Acomplia Rimonabant Zimulti available in Market now

However there are now websites offering generic Acomplia to US and UK customers. In nearly all cases the medication is coming from developing countries such as India and China. The manufacturers of these generics are not covered by any medical authority or body and as a result the ingredients in the drug may differ from what they claim which can lead to serious health risks.

We Strictly offer Branded Acomplia Rimonabant which is manufactured by Sanofi-Aventis.

Rimonabant is sold under the brand name Acomplia in Europe and by the brand name Zimulti in USA. EU Union has approved Acomplia for weight loss treatment but Zimulti is still waiting for the approval in USA from FDA.

Rimonabant Acomplia Helps With Weight Loss

Rimonabant acomplia is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels. Data from the World Health Organisation’s MONICA project show that in some parts of Europe over 70% of men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all Americans is obese and one in three overweight. Furthermore, increasing rates of childhood obesity are likely to exacerbate the trend towards increasing obesity in adulthood.

Rimonabant Acomplia is the first of a new class of drugs that block the cannabinoid receptor 1 (CB1). The CB1 receptor is thought to play an important role in certain aspects of human behavior and metabolism - specifically, it is thought to play a role in obesity and lipid glucose metabolism.

Rimonabant Side Effects.

Rimonabant Acomplia was said to be well tolerated in early tests. The only relatively common side effects were mild GI side effects and dizziness, and these were said to be transient.

A Miracle? Rimonabant Acomplia - a real pharmaceutical help for weight loss, metabolic syndrome, and HDL levels may be on the horizon . It is thought that Rimonabant Acomplia is available from 28th june 2006.And you can buy Rimonabant Acomplia online through prescription given by our doctor.

Please note that Rimonabant Acomplia is available to purchase, you can buy it anywhere as it has been released!

Rimonabant in UK:

Why not get a free obesity check-up online? Click here and fill in the form, the doctor will review it to see if you are suitable for treatment.

Rimonabant: A Miracle Fat-Fighting Drug
Imagine a drug that melts fat, boosts good cholesterol while reducing artery-choking triglycerides, and helps smokers kick the habit. What sounds almost too good to be true could soon be just a prescription away.

Rimonabant is the first drug designed to affect your endocannabinoid system, which influences energy balance, fat storage, cholesterol, and blood-sugar levels. In 2005, U.S. and European researchers reported 2-year results from rimonabant studies that are nothing short of astonishing.

In the American trial, 3,040 volunteers were put on a reduced-calorie diet. Some were given the drug; others, a placebo. After 2 years, the waistlines of volunteers on rimonabant were more than 3 inches smaller (compared with 1.5 inches in the placebo group); 30 percent lost more than a tenth of their body weight (compared with 16 percent with the others). Most surprising, the drug raised HDL, or good, cholesterol by a whopping 25 percent on average. “And there aren’t many other drugs that can do that,” says Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at Methodist DeBakey Heart Center in Houston. Rimonabant also lowers tri-glycerides and improves insulin sensitivity. For smokers reluctant to quit for fear of gaining weight, the drug may be particularly attractive. In early studies, it improved the odds of kicking the habit and prevented weight gain.

“We’re hopeful that in combination with diet and exercise, rimonabant will offer an entirely new way to fight the epidemic of obesity and diabetes,” Ballantyne says.

Whole grains: packaging helps you eat better
New dietary guidelines, released last year, made it official: We should all shoot for three or more 1-ounce whole-grain servings a day. Luckily, food manufacturers are making it easier. In September, foods from breakfast cereals and breads to energy bars began to bear the stamp of the nonprofit Whole Grains Council, which guarantees that a serving has at least 16 grams of whole grains. Not all manufacturers choose to use the stamp. But you can be sure that packaged foods marked “excellent” have one full serving; those marked “good” contain half a serving, or at least 8 grams. Results from the Nurses’ Health Study show why grains are so important: The more that women in the study consumed, the lower their risk of heart disease. A 2005 Tufts University study showed that whole-grain foods slowed the accumulation of arterial plaque.

Longevity: Good news for the pleasantly plump
Rarely has a single scientific study sparked such joy—and such outrage. Published in The Journal of the American Medical Association last April, a U.S. Centers for Disease Control and Prevention (CDC) analysis of nationwide data found that people who are overweight actually live longer than normal-weight people. Compared with underweight people, the plump have even more of a longevity advantage.

Previous studies suggested that more than 400,000 people die each year from being obese. The new analysis, led by epidemiologist Katherine Flegal, showed only 112,000 excess deaths and found that being underweight was linked in the study to some 33,000 deaths a year. The people with the lowest death rates were moderately overweight—with a body-mass index between 25 and 29.9.

Rimonabant Fda

• The best course of action to take sometimes isn’t clear until you’ve listed and considered your alternatives. The following paragraphs should help clue you in to what the experts think is significant.

• Truthfully, the only difference between you and Fda experts is time. If you’ll invest a little more time in reading, you’ll be that much nearer to expert status when it comes to Fda.

• A few days after the latest clinical results with rimonabant were published in the Feb. 15 issue of the Journal of the American Medical Association, the Food and Drug Administration declined to approve this widely anticipated new drug, according to the February 18 issue of the Wall Street Journal. Rimonabant (Sanofi-Aventis) has been causing excitement among physicians and patients alike during the past several years. Over that time, randomized clinical trials have shown that the drug can help with both sustainable weight loss and with smoking cessation.

• According to company spokesmen, the FDA last week issued an “approvable” lettter for the weight loss indication, but a “non-approvable” letter for smoking cessation.

• Early trials with rimonabant were very promising, and while many have cautioned that it’s way too early to get very excited about this drug, such cautions have been largely ignored. People have been chomping at the bit to get at rimonabant.

• Rimonabant is the first of a class of drugs, called CB1 blockers, that act on the endocannabinoid system (the EC system), a natural system that modulates the body’s energy balance and nicotine dependence. An over-stimulated EC system is thought to play a role both in obesity and in tobacco dependence, and CB1 blockers are supposed to reduce this overstimulation.

• The latest published clinical trial with rimonabant Fda, the RIO-North America study, showed that in 3040 patients treated for two years, 20 mg of rimonabant produced a significant reduction in weight, waist circumference, triglycerides, and in the percentage of patients with metabolic syndrome, as well as a significant increase in HDL levels, compared to placebo. Disturbingly, however, 50% of patients in both the rimonabant and placebo groups (and patients did not know which group they were in) dropped out before the study was finished. Furthermore, to maintain the favorable results, chronic therapy with rimonabant online- which will be a very expensive drug - appears necessary. In addition, while the weight loss and reduction in waist circumference were statistically significant as compared to placebo, they were not of impressive magnitude. The average weight loss over 2 years was about 15 pounds, and the average reduction in waist size was 2 - 4 inches. And finally, about 6% of patients on rimonabant reported anxiety, and 5% reported feeling depressed.

• Now might be a good time to write down the main points covered above. The act of putting it down on paper will help you remember what’s important about RimonabantFda.

Rimonabant accepted for filing by the FDA

Sanofi-aventis announced today that the United States Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers.

Rimonabant, discovered and developed by sanofi-aventis, is thought to represent a new approach for the comprehensive management of cardiovascular risk factors. The compound has been studied to date in over 6,500 overweight and obese adults for up to 2 years.

Despite therapeutic advances in recent decades, cardiovascular disease remains the leading cause of mortality worldwide. Current treatments generally target risk factors individually, rather than providing a comprehensive management approach to such cardiovascular risks as dyslipidemia, abdominal obesity and insulin resistance, which comprise the metabolic syndrome.

As the first selective CB1 blocker, the effects of rimonabant on lipid and glucose metabolism, insulin resistance and reduced intra-abdominal adiposity, evidenced by a reduction in waist circumference, have been studied. Abdominal obesity is recognized as a significant risk factor in the development of cardiovascular disease.

Rimonabant also has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking.

A Marketing Authorization Application to the European Medicines Agency (EMEA) for rimonabant has also been submitted.

About sanofi-aventis
Sanofi-aventis is the world’s third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. The sanofi-aventis Group is listed in Paris (EURONEXT: SAN) and in New York